Detalles de la búsqueda
1.
Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial.
Lancet Oncol;
18(5): 587-598, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28373007
2.
Pan-Bcl-2 inhibitor, GX15-070 (obatoclax), decreases human T regulatory lymphocytes while preserving effector T lymphocytes: a rationale for its use in combination immunotherapy.
J Immunol;
192(6): 2622-33, 2014 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24516200
3.
Identification by digital immunohistochemistry of intratumoral changes of immune infiltrates after vaccine in the absence of modifications of PBMC immune cell subsets.
Int J Cancer;
135(4): 862-70, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24474335
4.
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial.
Cancer Discov;
13(11): 2394-2411, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37707791
5.
Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients--a pilot study.
Support Care Cancer;
20(11): 2713-20, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22322591
6.
Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab.
Int J Colorectal Dis;
26(2): 143-51, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21188390
7.
Anti-PD-L1/TGFßR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis.
Urol Oncol;
36(3): 93.e1-93.e11, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29103968
8.
Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFß, in Advanced Solid Tumors.
Clin Cancer Res;
24(6): 1287-1295, 2018 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29298798
9.
Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody.
J Immunother Cancer;
5: 20, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28239472
10.
Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury.
Clin Cancer Res;
23(22): 6833-6845, 2017 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28855356
11.
A fully human IgG1 anti-PD-L1 MAb in an in vitro assay enhances antigen-specific T-cell responses.
Clin Transl Immunology;
5(5): e83, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27350882
12.
Analyses of 123 Peripheral Human Immune Cell Subsets: Defining Differences with Age and between Healthy Donors and Cancer Patients Not Detected in Analysis of Standard Immune Cell Types.
J Circ Biomark;
5: 5, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28936253
13.
The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy.
Oncoimmunology;
5(7): e1188243, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27622042
14.
Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy.
Cancer Immunol Res;
4(9): 755-65, 2016 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27485137
15.
The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells.
Oncotarget;
7(25): 37762-37772, 2016 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27192116
16.
Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial.
Oncotarget;
7(42): 69014-69023, 2016 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-27486817
17.
Inhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack.
J Immunother Cancer;
3: 52, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26579226
18.
Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury.
Cancer Immunol Res;
3(11): 1248-56, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26130065
19.
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial.
JAMA Oncol;
1(8): 1087-95, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26291768
20.
Immune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccines.
Cancer Immunol Res;
2(11): 1090-102, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25092771